Skip to main content
Clinical Trials/NCT06739005
NCT06739005
Recruiting
Not Applicable

artifiCiAl Intelligence Model for Evaluating the Surgical Techniques of caRdiAc Surgeons (CAMERA)

China National Center for Cardiovascular Diseases1 site in 1 country284 target enrollmentJanuary 9, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
CABG-patients
Sponsor
China National Center for Cardiovascular Diseases
Enrollment
284
Locations
1
Primary Endpoint
Consistency assessment between AI surgical evaluation scores and human expert scores.
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The goal of this study aims to investigate the use of artificial intelligence to analyze and evaluate the characteristics and proficiency of surgeons during vascular anastomosis in coronary artery bypass grafting (CABG) procedures. The main question it aims to answer is:

Consistency assessment between AI evaluation scores and human expert evaluation scores for surgeons during left anterior descending (LAD) artery anastomosis.

Registry
clinicaltrials.gov
Start Date
January 9, 2025
End Date
July 1, 2027
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
China National Center for Cardiovascular Diseases
Responsible Party
Principal Investigator
Principal Investigator

Shengshou Hu

Academician of Chinese Academy of Engineering President, Fuwai Hospital Director, National Center for Cardiovascular Diseases Director, NCRC Director, State Key Laboratory of Cardiovascular Disease Chairman, China Heart Congress (CHC) Former President

China National Center for Cardiovascular Diseases

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years
  • Undergoing internal mammary artery-to-left anterior descending artery bypass grafting
  • First-time recipient of isolated CABG surgery
  • Signed written informed consent

Exclusion Criteria

  • Patients with acute coronary syndrome
  • Patients with contraindications to coronary CT angiography or coronary angiography
  • Patients with renal insufficiency or active liver disease, including those with persistently elevated serum transaminases of unknown cause or any serum transaminase levels exceeding three times the upper limit of normal.

Outcomes

Primary Outcomes

Consistency assessment between AI surgical evaluation scores and human expert scores.

Time Frame: At the end of enrollment

Secondary Outcomes

  • Intraoperative measurement of graft flow and flow resistance.(After enrollment)
  • Characteristics of the surgeon's motion trajectory.(After enrollment)
  • Consistency assessment between AI surgical evaluation scores levels and human expert scores levels.(After enrollment)

Study Sites (1)

Loading locations...

Similar Trials